Obesity, subclinical myocardial injury, and incident heart failure

JACC: Heart Failure

Volumn 2, Issue 6, 2014, Pages 600-607

  Ndumele, Chiadi E ^a,b   Coresh, Josef ^b   Lazo, Mariana ^a,b   Hoogeveen, Ron C ^c   Blumenthal, Roger S ^a   Folsom, Aaron R ^d   Selvin, Elizabeth ^b   Ballantyne, Christie M ^c   Nambi, Vijay ^c,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Heart failure; Obesity; Troponin

Indexed keywords

TROPONIN T; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROGNOSIS; WAIST CIRCUMFERENCE; COMPLICATION; CORONARY ARTERY DISEASE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

BIOMARKERS; BODY MASS INDEX; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TROPONIN T; WAIST CIRCUMFERENCE;

EID: 84959935660     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.05.017     Document Type: Article

References (23)

1. Jessup M., Abraham W.T., Casey D.E., et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:1343-1382.
2. Lavie C.J., Alpert M.A., Arena R., Mehra M.R., Milani R.V., Ventura H.O. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JAm Coll Cardiol HF 2013, 1:93-102.
3. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898-918.
4. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. NEngl J Med 2002, 347:305-313.
5. Abel E.D., Litwin S.E., Sweeney G. Cardiac remodeling in obesity. Physiol Rev 2008, 88:389-419.
6. Zalesin K.C., Franklin B.A., Miller W.M., Peterson E.D., McCullough P.A. Impact of obesity on cardiovascular disease. Med Clin North Am 2011, 95:919-937.
7. Choi E.Y., Yan R.T., Fernandes V.R., et al. High-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: the multiethnic study of atherosclerosis. Am Heart J 2012, 164:251-258.
8. Martin S.S., Qasim A., Reilly M.P. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. JAm Coll Cardiol 2008, 52:1201-1210.
9. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56:254-261.
10. deFilippi C.R., de Lemos J.A., Christenson R.H., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
11. Saunders J.T., Nambi V., de Lemos J.A., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123:1367-1376.
12. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989, 129:687-702. The ARIC Investigators.
13. de Lemos J.A., Drazner M.H., Omland T., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
14. Chen Y.T., Vaccarino V., Williams C.S., Butler J., Berkman L.F., Krumholz H.M. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999, 106:605-612.
15. He J., Ogden L.G., Bazzano L.A., Vupputuri S., Loria C., Whelton P.K. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001, 161:996-1002.
16. Wilhelmsen L., Rosengren A., Eriksson H., Lappas G. Heart failure in the general population of men-morbidity, risk factors and prognosis. JIntern Med 2001, 249:253-261.
17. Rubin J., Matsushita K., Ballantyne C.M., Hoogeveen R., Coresh J., Selvin E. Chronic hyperglycemia and subclinical myocardial injury. JAm Coll Cardiol 2012, 59:484-489.
18. Pervanidou P., Akalestos A., Bastaki D., Apostolakou F., Papassotiriou I., Chrousos G. Increased circulating High-Sensitivity Troponin T concentrations in children and adolescents with obesity and the metabolic syndrome: A marker for early cardiac damage?. Metabolism 2013, 62:527-531.
19. Turkbey E.B., McClelland R.L., Kronmal R.A., et al. The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JAm Coll Cardiol Img 2010, 3:266-274.
20. Barouch L.A., Gao D., Chen L., et al. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 2006, 98:119-124.
21. Zhou Y.T., Grayburn P., Karim A., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000, 97:1784-1789.
22. Vincent H.K., Powers S.K., Dirks A.J., Scarpace P.J. Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord 2001, 25:378-388.
23. Garg S., Narula J., Chandrashekhar Y. Apoptosis and heart failure: clinical relevance and therapeutic target. JMol Cell Cardiol 2005, 38:73-79.